Global X Management Company’s Agios Pharmaceuticals AGIO Stock Holding History

Global X Management Company’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$62K	Buy	+733	New	+$63.9K	﹤0.01%	1055

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Global X Management Company's AGIO Position: Q2 2018 in Review

Global X Management Company opened a new position in Agios Pharmaceuticals (AGIO) in Q2 2018: 733 shares worth $62K. The stake represents ﹤0.01% of the portfolio and ranks #1055 among its holdings.

217 funds tracked by Wall St. Rank hold AGIO as of Q2 2018.

Global X Management Company held 733 shares of Agios Pharmaceuticals worth $62K as of Q2 2018.
Agios Pharmaceuticals was a new Global X Management Company position in Q2 2018.
Agios Pharmaceuticals made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1055 holding.
217 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.